TE_22699
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1MC4a_3end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | BET1L |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 0.03 |
| Counts of samples | TCGA_tumor:4; TCGA_normal:0; GTEx:169 |
| TSS | chr11(-):179451 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_22699.1 | BET1L | Chimeric | Non-coding | Non-coding | chr11(-):167864,167884,168943,169052,179372,179452 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
